Dupont Capital Management Corp Aerie Pharmaceuticals Inc Transaction History

Dupont Capital Management Corp

  • $1.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 29, 2020
SELL
$11.84 - $25.52 $170,756 - $368,049
-14,422 Closed
0 $0
Q3 2019

Oct 28, 2019
SELL
$18.41 - $28.0 $63,017 - $95,844
-3,423 Reduced 19.18%
14,422 $277,000
Q2 2019

Jul 30, 2019
BUY
$28.97 - $48.21 $88,300 - $146,944
3,048 Added 20.6%
17,845 $527,000
Q1 2019

Apr 30, 2019
BUY
$36.32 - $49.25 $537,427 - $728,752
14,797 New
14,797 $703,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email